The cell-membrane prothrombinase, fibrinogen-like protein 2, promotes angiogenesis and tumor development

Thrombosis Research

Volumn 136, Issue 1, 2015, Pages 118-124

  Rabizadeh, Esther ^a,b   Cherny, Izhack ^a   Lederfein, Doron ^a   Sherman, Shany ^a   Binkovsky, Natalia ^a   Rosenblat, Yevgenia ^b   Inbal, Aida ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

Angiogenesis; Fibrinogen like protein 2; Tumorigenesis

Indexed keywords

ANGIOGENIC PROTEIN; BLOOD CLOTTING FACTOR 10A; FIBRINOGEN LIKE PROTEIN 2; FIBRINOGEN VARIANT; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; HIRUDIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; SMALL INTERFERING RNA; THROMBIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; FGL2 PROTEIN, HUMAN; FIBRINOGEN; THROMBOPLASTIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; MOLECULAR PATHOLOGY; MOUSE; NEOPLASM; NONHUMAN; PC 3 CELL LINE; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; PROTEOMICS; SCID MOUSE; SIGNAL TRANSDUCTION; TUMOR DIFFERENTIATION; TUMOR XENOGRAFT; UMBILICAL VEIN ENDOTHELIAL CELL; WILD TYPE; ANIMAL; CELL PROLIFERATION; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROSTATE; PROSTATE TUMOR; RNA INTERFERENCE; TUMOR CELL LINE;

ANIMALS; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; FIBRINOGEN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC; PROSTATE; PROSTATIC NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; THROMBIN; THROMBOPLASTIN;

EID: 84931568993     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.11.023     Document Type: Article

References (37)

1. A. Trousseau Clinique Medical de l'Hotel-dieu de Paris, Phlegmasia Alba Dolens 1865 JB Balliere et Fils Paris 654 715
2. J.W. Blom, C.J. Doggen, S. Osanto, and F.R. Rosendaal Malignancies, prothrombotic mutations, and the risk of venous thrombosis JAMA 293 2005 715 722
3. J.W. Blom, J.P. Vanderschoot, M.J. Oostindier, S. Osanto, F.J. van der Meer, and F.R. Rosendaal Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study J Thromb Haemost 4 2006 529 535
4. H.T. Sorensen, L. Mellemkjaer, J.H. Olsen, and J.A. Baron Prognosis of cancers associated with venous thromboembolism N Engl J Med 343 2000 1846 1850
5. J.W. Blom, S. Osanto, and F.R. Rosendaal High risk of venous thrombosis in patients with pancreatic cancer: a cohort study of 202 patients Eur J Cancer 42 2006 410 414
6. I. Kim, S.O. Moon, K.N. Koh, H. Kim, C.S. Uhm, and H.J. Kwak Molecular cloning, expression, and characterization of angiopoietin-related protein. angiopoietin-related protein induces endothelial cell sprouting J Biol Chem 274 1999 26523 26528
7. K. Su, F. Chen, W.M. Yan, Q.L. Zeng, L. Xu, and D. Xi Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma World J Gastroenterol 14 2008 5980 5989
8. Q. Ning, Y. Sun, M. Han, L. Zhang, C. Zhu, and W. Zhang Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejection J Immunol 174 2005 7403 7411
9. C.W. Chan, M.W. Chan, M. Liu, L. Fung, E.H. Cole, and J.L. Leibowitz Kinetic analysis of a unique direct prothrombinase, fgl2, and identification of a serine residue critical for the prothrombinase activity J Immunol 168 2002 5170 5177
10. T. Koyama, L.R. Hall, W.G. Haser, S. Tonegawa, and H. Saito Structure of a cytotoxic T-lymphocyte-specific gene shows a strong homology to fibrinogen beta and gamma chains Proc Natl Acad Sci U S A 84 1987 1609 1613
11. G.A. Levy, M. Liu, J. Ding, S. Yuwaraj, J. Leibowitz, and P.A. Marsden Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis Am J Pathol 156 2000 1217 1225
12. S. Yuwaraj, J. Ding, M. Liu, P.A. Marsden, and G.A. Levy Genomic characterization, localization, and functional expression of FGL2, the human gene encoding fibroleukin: a novel human procoagulant Genomics 71 2001 330 338
13. S. Marazzi, S. Blum, R. Hartmann, D. Gundersen, M. Schreyer, and S. Argraves Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes J Immunol 161 1998 138 147
14. C.W. Chan, L.S. Kay, R.G. Khadaroo, M.W. Chan, S. Lakatoo, and K.J. Young Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells J Immunol 170 2003 4036 4044
15. J.W. Ding, Q. Ning, M.F. Liu, A. Lai, J. Leibowitz, and K.M. Peltekian Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase J Virol 71 1997 9223 9230
16. A. Ghanekar, M. Mendicino, H. Liu, W. He, M. Liu, and R. Zhong Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection J Immunol 172 2004 5693 5701
17. W.W. Hancock, F.M. Szaba, K.N. Berggren, M.A. Parent, I.K. Mullarky, and J. Pearl Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2 Proc Natl Acad Sci U S A 101 2004 3005 3010
18. Y. Liu, L. Xu, Q. Zeng, J. Wang, M. Wang, and D. Xi Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis Liver Int 32 2012 1585 1595
19. N. Tarasenko, S.M. Cutts, D.R. Phillips, A. Inbal, A. Nudelman, and G. Kessler-Icekson Disparate impact of butyroyloxymethyl diethylphosphate (AN-7), a histone deacetylase inhibitor, and doxorubicin in mice bearing a mammary tumor PLoS One 7 2012 e31393
20. M.E. Kaighn, K.S. Narayan, Y. Ohnuki, J.F. Lechner, and L.W. Jones Establishment and characterization of a human prostatic carcinoma cell line (PC-3) Invest Urol 17 1979 16 23
21. S.M. Pulukuri, C.S. Gondi, S.S. Lakka, A. Jutla, N. Estes, and M. Gujrati RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo J Biol Chem 280 2005 36529 36540
22. P.G. Corn, F. Wang, W.L. McKeehan, and N. Navone Targeting fibroblast growth factor pathways in prostate cancer Clin Cancer Res 19 2013 5856 5866
23. T. Browder, J. Folkman, and S. Pirie-Shepherd The hemostatic system as a regulator of angiogenesis J Biol Chem 275 2000 1521 1524
24. N.E. Tsopanoglou, E. Pipili-Synetos, and M.E. Maragoudakis Thrombin promotes angiogenesis by a mechanism independent of fibrin formation Am J Physiol 264 1993 C1302 C1307
25. T.A. Hembrough, G.M. Swartz, A. Papathanassiu, G.P. Vlasuk, W.E. Rote, and S.J. Green Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism Cancer Res 63 2003 2997 3000
26. R. Dardik, J. Loscalzo, and A. Inbal Factor XIII (FXIII) and angiogenesis J Thromb Haemost 4 2006 19 25
27. A. Falanga, M. Panova-Noeva, and L. Russo Procoagulant mechanisms in tumour cells Best Pract Res Clin Haematol 22 2009 49 60
28. A. Falanga, M. Marchetti, and A. Vignoli Coagulation and cancer: biological and clinical aspects J Thromb Haemost 11 2013 223 233
29. N. Selzner, H. Liu, M.U. Boehnert, O.A. Adeyi, I. Shalev, and A.M. Bartczak FGL2/fibroleukin mediates hepatic reperfusion injury by induction of sinusoidal endothelial cell and hepatocyte apoptosis in mice J Hepatol 56 2012 153 159
30. M. Hollborn, L. Kohen, C. Werschnik, L. Tietz, P. Wiedemann, and A. Bringmann Activated blood coagulation factor X (FXa) induces angiogenic growth factor expression in human retinal pigment epithelial cells Invest Ophthalmol Vis Sci 53 2012 5930 5939
31. M.A. Nugent, and R.V. Iozzo Fibroblast growth factor-2 Int J Biochem Cell Biol 32 2000 115 120
32. V.P. Eswarakumar, I. Lax, and J. Schlessinger Cellular signaling by fibroblast growth factor receptors Cytokine Growth Factor Rev 16 2005 139 149
33. G. Yan, Y. Fukabori, G. McBride, S. Nikolaropolous, and W.L. McKeehan Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy Mol Cell Biol 13 1993 4513 4522
34. S. Feng, F. Wang, A. Matsubara, M. Kan, and W.L. McKeehan Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells Cancer Res 57 1997 5369 5378
35. F. Yang, Y. Zhang, S.J. Ressler, M.M. Ittmann, G.E. Ayala, and T.D. Dang FGFR1 is essential for prostate cancer progression and metastasis Cancer Res 73 2013 3716 3724
36. U.V. Wesley, M. McGroarty, and A. Homoyouni Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway Cancer Res 65 2005 1325 1334
37. F. Yang, D.W. Strand, and D.R. Rowley Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma Oncogene 27 2008 450 459